{"id":"W3111215912","doi":"10.1016/j.jcf.2020.11.003","title":"A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutation","year":2020,"lang":"en","type":"article","venue":"Journal of Cystic Fibrosis","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Vertex Pharmaceuticals","keywords":"Ivacaftor; Medicine; Cystic fibrosis; Internal medicine; Clinical endpoint; Randomized controlled trial; Gating; Mutation; Crossover study; Gastroenterology; Cystic fibrosis transmembrane conductance regulator; Physiology; Pathology; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002387425,0.0005196397,0.002135034,0.0006294018,0.000176309,0.0002201791,0.0002902389,0.0001059307,0.00005294663],"category_scores_gemma":[0.004511426,0.0003826022,0.0003254687,0.001023046,0.0001546126,0.0005230104,0.0001258553,0.0005563536,0.00001095578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002995705,"about_ca_system_score_gemma":0.0003449767,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001370246,"about_ca_topic_score_gemma":0.00004891072,"domain_scores_codex":[0.9947626,0.0004640656,0.001834358,0.0006541507,0.001547365,0.000737466],"domain_scores_gemma":[0.9942374,0.002862071,0.0008441935,0.0003190415,0.0007743986,0.0009629405],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9544244,0.001820047,0.002570502,0.001135652,0.0005787376,0.0003007521,0.003559781,0.003257889,0.02791997,0.00001338066,0.0002867388,0.004132178],"study_design_scores_gemma":[0.9036343,0.05078248,0.004066676,0.001995116,0.001953696,0.0008035697,0.005102764,0.02944082,0.001172313,0.0001605896,0.0002642277,0.0006234796],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9223804,0.0009989508,0.06915494,0.001066102,0.00005476452,0.006242225,0.00004480314,0.00003995441,0.00001780105],"genre_scores_gemma":[0.875748,0.00002199001,0.122948,0.0002391127,0.0003536729,0.0005522986,0.00002395448,0.00008624189,0.00002665341],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05379308,"threshold_uncertainty_score":0.9998626,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03560602796098297,"score_gpt":0.3603029948497579,"score_spread":0.3246969668887749,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}